http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
이정근(J.G. Lee),최석준(S.J. Choi),이세현(H.S. Jung),정희석(H.S. Jung),권기태(K.T. Kwon),박노준(N.J. Park),황명근(M.K. Hwang) 한국조명·전기설비학회 2011 한국조명·전기설비학회 학술대회논문집 Vol.2011 No.11
In this paper, I try to measure the electrical characteristics of PV(photovoltaic) cell for street lighting with solar simulator and simulated with PC1D software. I keep my eye on the characteristics variation of PV cell as a temperature change. Therefore, I try to increase a temperature of controlled block from 10℃ to 60℃ while measuring the PV cell. As a result, A variation caused by voltage have an effect on the efficacy of PV cell. Hence, it is an important variable when a designer plan to make a solar cell for street lighting.
Pemetrexed/cisplatin 병합 2차 항암화학요법에 극적 반응을 보인 악성 흉막 중피종
이승민 ( Seung Min Lee ),고순영 ( Soon Young Ko ),서태호 ( Tae Ho Seo ),이정현 ( Jung Hyun Lee ),최승오 ( Seung Oh Choi ),이정근 ( Jeong Geun Lee ),김완섭 ( Wan Seop Kim ),이태훈 ( Tae Hoon Lee ),유광하 ( Gwang Ha Yoo ),이계영 ( K 대한결핵 및 호흡기학회 2007 Tuberculosis and Respiratory Diseases Vol.62 No.5
Malignant pleural mesothelioma (MPM) is a rare tumor that is difficult to clearly distinguish from an adenocarcinoma but usually has a poor prognosis. Numerous cytotoxic agents have been used in the primary treatment of MPM with limited success. A complete response is unusual and a partial response occurs in less than one-third of patients. Recently, a phase III trial showed that a combination of pemetrexed with cisplatin resulted in a significantly higher response rate and median survival time than with cisplatin alone. We encountered a case of a dramatic tumor response to pemetrexed/cisplatin combination chemotherapy in patients with MPM, which was resistant to the 1st-line gemcitabine/cisplatin therapy. After six cycles of pemetrexed/cisplatin combination chemotherapy, the tumor volume had decreased dramatically with complete symptom relief. There was no chemotherapy-related toxicity or scheduled violation. The patient is under maintenance chemotherapy with the same regimen. (Tuberc Respir Dis 2007; 62: 432-436)